EX-21.1
Published on April 26, 2024
EXHIBIT 21.1
Scorpius Holdings, Inc. Subsidiaries
Name of Subsidiary |
Jurisdiction |
|
Heat Biologics I, Inc |
Delaware |
Heat Biologics III, Inc. |
Delaware |
Heat Biologics IV, Inc. |
Delaware |
Heat Biologics GmbH |
Germany |
Heat Biologics Australia Pty LTD |
Australia |
Zolovax, Inc. |
Delaware |
Pelican Therapeutics, Inc.1 |
Delaware |
Skunkworx Labs, Inc.3 |
Delaware |
Delaware |
|
Abacus Biotech, Inc.3 |
Delaware |
Blackhawk Bio, Inc.3 |
Delaware |
|
|
1Formerly Heat Biologics II, Inc. believed to be formed in 2008 and divested in 2012. Refer to 2020 10-K.
Jeffrey Wolf was issued an option to purchase up to 5% of the outstanding shares of Scorpius Biomanufacturing, Inc. and William Ostrander was issued an option to purchase up to 1% of the outstanding shares of Scorpius Biomanufacturing, Inc., both options were exercised in full.
3Each of these entities are parties to a subsidiary incentive plan pursuant to which options have been issued.